Status:
COMPLETED
The Effect of Pranayama Breathing Exercise on Quality of Life in Lung Cancer Patients
Lead Sponsor:
Sanko University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research is a randomized controlled experimental study to determine the effect of pranayama breathing exercise applied to patients with lung cancer on quality of life.
Detailed Description
The population of the study consists of patients with primary diagnosis of lung cancer who applied to Erciyes University Health Practice and Research Center Nazende-Nuri Özkaya Oncology Day Treatment ...
Eligibility Criteria
Inclusion
- Over 18 years old,
- Lung Cancer Stage III and IV,
- Being literate,
- Having sufficient communication skills,
- Does not have any ailment that will reduce the ability to comprehend and understand,
- Agreeing to participate in the research,
- Knowing the diagnosis,
- Receiving chemotherapy treatment,
- ECOG performance score ≤ 2,
- Not using opioids or sedating drugs,
- Patients who can use smart phones themselves or their relatives will be included in the study
Exclusion
- Lung Cancer I., II., stage,
- Receiving radiotherapy,
- Having a history of Brain Metastasis,
- Using integrated health practices in the treatment process,
- Those who exercise regularly
- For patients over 65 years of age, patients with a score below 24 on the mini mental test were not included in the study.
- Research Termination Criteria
- Intervention Group
- Developing additional health problems,
- Unwilling to continue the practice of pranayama breathing exercise,
- Those who lost their lives during the research process,
- Those who do not practice pranayama breathing exercise as recommended or cannot do it effectively,
- The study will be terminated with patients who want to withdraw from the study.
- Control Group
- Developing additional health problems,
- Those who lost their lives during the research process,
- The study will be terminated with patients who want to withdraw from the study.
Key Trial Info
Start Date :
January 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05985824
Start Date
January 6 2023
End Date
January 27 2024
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes University
Kayseri, Talas, Turkey (Türkiye)